Chapter 29. Basal Cell Carcinoma

  1. Hywel Williams MSC, PhD, FRCP Professor Dermato-Epidemiology Co-ordinating Editor
  1. Fiona Bath-Hextall BSC(Hon), PhD Associate Professor1 and
  2. William Perkins MB, MS, FRCP Consultant Dermatologist2

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300161.ch29

Evidence-Based Dermatology, Second Edition

Evidence-Based Dermatology, Second Edition

How to Cite

Bath-Hextall, F. and Perkins, W. (2008) Basal Cell Carcinoma, in Evidence-Based Dermatology, Second Edition (ed H. Williams), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300161.ch29

Editor Information

  1. Centre of Evidence-Based Dermatology, Nottingham University Hospital NHS Trust, Queen's Medical Centre, Nottingham, UK

Author Information

  1. 1

    Centre for Evidence-based Dermatology, University of Nottingham, Nottingham, UK

  2. 2

    Department of Dermatology, Nottingham University Hospitals, Nottingham, UK

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405145183

Online ISBN: 9781444300161



  • basal cell carcinoma (BCC) - invasive malignant epidermal skin tumor;
  • nodular basal cell carcinoma;
  • morpheic basal cell carcinoma;
  • surgery versus photodynamic therapy;
  • Mohs micrographic surgery (MMS);
  • cryotherapy versus surgical excision;
  • verteporfin and red light–dose-ranging study;
  • 5-FU/epinephrine gel efficacy


This chapter contains sections titled:

  • Background

  • Questions: What are the effective therapeutic interventions for BCC of the skin? How do the therapeutic interventions for BCC compare with each other? How do the cosmetic outcomes for these interventions compare? Are these interventions cost-effective?

  • References